Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pia Jaatinen is active.

Publication


Featured researches published by Pia Jaatinen.


Clinical Endocrinology | 2004

Long-term follow-up study of radioiodine treatment of hyperthyroidism

Saara Metso; Pia Jaatinen; Heini Huhtala; Tiina Luukkaala; Heikki Oksala; Jorma Salmi

objective  To determine the cumulative incidence of hypothyroidism during long‐term follow‐up in patients treated for hyperthyroidism by radioactive iodine 131I (RAI) therapy, the significance of clinical factors in predicting the development of hypothyroidism, and the outcome after a fixed 7 mCi (259 MBq) dose of RAI.


Cancer | 2007

Increased cancer incidence after radioiodine treatment for hyperthyroidism

Saara Metso; Anssi Auvinen; Heini Huhtala; Jorma Salmi; Heikki Oksala; Pia Jaatinen

Concerns remain about risk of cancer after radioactive iodine (RAI) treatment for hyperthyroidism, especially in organs that concentrate iodine. The objective was to assess the long‐term cancer risk from RAI treatment for hyperthyroidism.


The Cerebellum | 2008

Mechanisms of ethanol-induced degeneration in the developing, mature, and aging cerebellum

Pia Jaatinen; Jyrki Rintala

The adverse effects of acute and chronic ethanol exposure on cerebellar functions have been acknowledged for decades, in terms of impaired control of movement and balance. In addition to the motor impairment, cerebellar degeneration has recently been shown to contribute to distinct neuropsychological deficits in chronic alcoholics, as well as in children with prenatal ethanol exposure. The basic mechanisms underlying these ethanol-induced functional alterations and the related neuropathology in the cerebellum have mostly been clarified only recently. These mechanisms include: (i) excitotoxicity; (ii) dietary factors, especially thiamine depletion; (iii) glial abnormalities; (iv) changes in growth factors; (v) apoptotic mechanisms; (vi) oxidative stress; and (vii) compromised energy production. Although these mechanisms widely apply not only to the mature cerebellum, but also to the developing and the aging cerebella, the developing and the aged cerebellum have some special characteristics, which may make them even more vulnerable to ethanol-induced degeneration. These special instances will be discussed along with the general mechanisms of ethanol-induced cerebellar degeneration.


Journal of Family Nursing | 2013

Interrelation between adult persons with diabetes and their family: a systematic review of the literature.

Tuula-Maria Rintala; Pia Jaatinen; Eija Paavilainen; Päivi Åstedt-Kurki

Diabetes mellitus is a common chronic disease all over the world. Self-management plays a crucial role in diabetes management. The purpose of this systematic review was to summarize what is known about the interactions between adult persons with diabetes, their family, and diabetes self-management. MEDLINE, CINAHL, PSYCHINFO, LINDA, and MEDIC databases were searched for the years 2000 to 2011 and for English language articles, and the reference lists of the studies included were reviewed to capture additional studies. The findings indicate that family members have influence on the self-management of adult persons with diabetes. The support from family members plays a crucial role in maintaining lifestyle changes and optimizing diabetes management. Diabetes and its treatment also affect the life of family members in several ways, causing, for example, different types of psychological distress. More attention should be paid to family factors in diabetes management among adult persons.


Scandinavian Journal of Gastroenterology | 2012

Gluten-free diet and autoimmune thyroiditis in patients with celiac disease. A prospective controlled study.

Saara Metso; Henni Hyytiä-Ilmonen; Katri Kaukinen; Heini Huhtala; Pia Jaatinen; Jorma Salmi; Jyrki Taurio; Pekka Collin

Abstract Objective. Early diagnosis and dietary treatment with a gluten-free diet might slow down the progression of associated autoimmune diseases in celiac disease, but the data are contradictory. We investigated the course of autoimmune thyroid diseases in newly diagnosed celiac disease patients before and after gluten-free dietary treatment. Material and methods. Twenty-seven consecutive adults with newly diagnosed celiac disease were investigated at the time of diagnosis and after 1 year on gluten-free diet. Earlier diagnosed and subclinical autoimmune thyroid diseases were recorded and examined. Thyroid gland volume and echogenicity were measured by ultrasound. Autoantibodies against celiac disease and thyroiditis, and thyroid function tests were determined. For comparison, 27 non-celiac controls on normal gluten-containing diet were examined. Results. At the time of diagnosis, the celiac disease patients had more manifest (n = 7) or subclinical (n = 3) thyroid diseases than the controls (10/27 vs. 3/27, p = 0.055). During the follow-up, the thyroid volume decreased significantly in the patients with celiac disease compared with the controls, indicating the progression of thyroid gland atrophy despite the gluten-free diet. Conclusions. Celiac patients had an increased risk of thyroid autoimmune disorders. A gluten-free diet seemed not to prevent the progression of autoimmune process during a follow-up of 1 year.


Alcohol | 2001

Dose-dependent decrease in glial fibrillary acidic protein-immunoreactivity in rat cerebellum after lifelong ethanol consumption

Jyrki Rintala; Pia Jaatinen; Kalervo Kiianmaa; Jarno Riikonen; Oili Kemppainen; Antti Hervonen

The effects of aging and lifelong ethanol consumption on astrocytic morphology and glial fibrillary acidic protein-immunoreactivity (GFAP-IR) in the cerebellar vermis obtained from ethanol-preferring Alko, Alcohol (AA) rats were analyzed by using computer-assisted image analysis. The ethanol-consuming animals (both male and female) were given ethanol (10%-12%, vol./vol.) as the only available fluid for 21 months (3-24 months), whereas the young (3 months) and the old (24 months) controls received water. In the male rats, but not in the female rats, an age-related decrease in GFAP-IR was found in folia II, VII, and X of the molecular layer, and in turn, an age-related increase was found in folium X of the granular layer, indicating opposite changes in GFAP-IR for male rats due to aging in adjacent brain regions. In the female rats, 21 months of daily average ethanol consumption of 6.6 g/kg resulted in decreased GFAP-IR in folium VII of the molecular layer, and the decrease in cerebellar GFAP-IR correlated with the average daily ethanol intake (r=-.886, P=.019) when folia II, IV, VII, and X were analyzed together. No effect of ethanol on GFAP-IR was detected in the granular layer or in the central white matter of the female rats. There was no change in GFAP-IR in any of the three cerebellar layers of the male rats with average daily ethanol consumption of 3.2 g/kg. These results indicate that the Bergmann glial fibers are the GFAP-expressing structures of the cerebellum most sensitive to moderate-to-heavy chronic ethanol exposure and that this effect is dose dependent.


Alcohol | 1997

Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat

Päivi Riihioja; Pia Jaatinen; Hanna Oksanen; Antti Haapalinna; Esa Heinonen; Antti Hervonen

The effect of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on ethanol withdrawal symptoms was studied in chronically ethanol-fed rats. After a 4-day ethanol intoxication period the rats were given s.c. injections of dexmedetomidine (3, 10, or 30 micrograms/kg) or saline (control group) at 10, 16, 22, and 39 h after the last dose of ethanol. The severity of ethanol withdrawal symptoms (rigidity, tremor, irritability, hypoactivity) was rated up to 58 h, blind to the treatments. The results showed that dexmedetomidine at doses 10 and 30 micrograms/kg significantly diminished the severity of the ethanol withdrawal reaction as measured by the sum score of the three most specific withdrawal signs (rigidity, tremor, and irritability). Dexmedetomidine at 10 micrograms/kg was the most effective dose, especially in the latter half of the withdrawal period (23-58 h after last dose of ethanol). The results suggest that dexmedetomidine in the treatment of ethanol withdrawal symptoms should be further studied.


Clinical Endocrinology | 2010

Increased cancer incidence in acromegaly - a nationwide survey

Ritva Kauppinen-Mäkelin; Timo Sane; Matti Välimäki; Helene Markkanen; Leo Niskanen; Tapani Ebeling; Pia Jaatinen; Markus Juonala; Eero Pukkala

inapparent adrenal mass (‘‘incidentaloma’’) (2002) NIH Consensus and State-of-the-Science Statements 19, 1–23. http://consensus. nih.gov/2002/2002AdrenalIncidentalomasos021pdf.pdf (accessed 28 September 2009) 3 Mantero, F., Terzolo, M., Arnaldi, G. et al. (2000) A survey on adrenal incidentaloma in Italy. Journal of Clinical Endocrinology and Metabolism, 85, 637–644. 4 Arnaldi, G., Angeli, A., Atkinson, A.B. et al. (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 88, 5593–5602. 5 Nunes, M.L., Vattaut, S., Corcuff, J.B. et al. (2009) Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalised and ambulatory patients. Journal of Clinical Endocrinology and Metabolism, 94, 56–62.


Clinical Endocrinology | 2007

Increased long‐term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism

Saara Metso; Anssi Auvinen; Jorma Salmi; Heini Huhtala; Pia Jaatinen

Objective  Previous studies suggest that hyperthyroid patients remain at increased risk of cardiovascular morbidity after restoring euthyroidism. The aim of this study was to compare the rate and causes of hospitalization of hyperthyroid patients treated with radioactive iodine (RAI) with those of an age‐ and gender‐matched reference population in a long‐term follow‐up study.


Alcohol | 2003

Interaction of aging and intermittent ethanol exposure on brain cytochrome c oxidase activity levels

Pia Jaatinen; Jarno Riikonen; Päivi Riihioja; Olli A. Kajander; Antti Hervonen

The effects of chronic, intermittent ethanol exposure on brain cytochrome c oxidase (CO) activity levels were studied in young (3- to 4-month-old) and aged (29- to 30-month-old) male Wistar rats. The rats were given highly intoxicating doses of ethanol three times a day by intragastric intubation for four successive days, followed by a 3-day ethanol-withdrawal period. This 4-day ethanol-exposure with 3-day ethanol-withdrawal cycle was repeated five times to simulate the binge drinking of human alcoholics. The histochemical demonstration of CO showed a markedly decreased activity level in the medial prefrontal cortex (especially layer V pyramids and neuropil) of the ethanol-exposed rats of both age groups compared with findings for the respective controls. In the cerebellar vermis, CO activity level was decreased in the Purkinje neurons of the aged ethanol-exposed rats and in the granule cells of both young and aged ethanol-exposed rats. The CO activity level in the locus coeruleus was decreased in both young and old ethanol-exposed rats, but the decrease was more pronounced in the young ethanol-exposed group. Aging per se did not markedly change CO histochemical findings in either prefrontal or cerebellar cortex, but CO activity levels were increased in the locus coeruleus. In summary, results of the current study support our conclusion that CO activity levels were decreased in the cerebral and cerebellar cortices as well as in the locus coeruleus-CNS regions known to be negatively affected by chronic ethanol exposure. Defective energy metabolism due to decreased CO activity levels might compromise neuronal energy stores and thereby contribute to ethanol-induced brain dysfunction and irreversible CNS degeneration.

Collaboration


Dive into the Pia Jaatinen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kalervo Kiianmaa

National Institute for Health and Welfare

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Matti Välimäki

Helsinki University Central Hospital

View shared research outputs
Top Co-Authors

Avatar

Tapani Ebeling

Oulu University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge